188 related articles for article (PubMed ID: 31619723)
1. Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence.
Lestari B; Nakamae I; Yoneda-Kato N; Morimoto T; Kanaya S; Yokoyama T; Shionyu M; Shirai T; Meiyanto E; Kato JY
Sci Rep; 2019 Oct; 9(1):14867. PubMed ID: 31619723
[TBL] [Abstract][Full Text] [Related]
2. Combination of Potassium Pentagamavunon-0 and Doxorubicin Induces Apoptosis and Cell Cycle Arrest and Inhibits Metastasis in Breast Cancer Cells.
Putri H; Jenie RI; Handayani S; Kastian RF; Meiyanto E
Asian Pac J Cancer Prev; 2016; 17(5):2683-8. PubMed ID: 27268651
[TBL] [Abstract][Full Text] [Related]
3. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
4. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth.
Larasati YA; Yoneda-Kato N; Nakamae I; Yokoyama T; Meiyanto E; Kato JY
Sci Rep; 2018 Feb; 8(1):2039. PubMed ID: 29391517
[TBL] [Abstract][Full Text] [Related]
5. Pentagamavunone-1 inhibits aggressive breast cancer cell proliferation through mitotic catastrophe and ROS-mediated activities:
Novitasari D; Nakamae I; Istighfari Jenie R; Yoneda-Kato N; Kato JY; Meiyanto E
Saudi Pharm J; 2024 Jan; 32(1):101892. PubMed ID: 38146327
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation.
Meiyanto E; Putri H; Arum Larasati Y; Yudi Utomo R; Istighfari Jenie R; Ikawati M; Lestari B; Yoneda-Kato N; Nakamae I; Kawaichi M; Kato JY
Adv Pharm Bull; 2019 Aug; 9(3):445-452. PubMed ID: 31592109
[No Abstract] [Full Text] [Related]
7. Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction.
Zheng A; Li H; Wang X; Feng Z; Xu J; Cao K; Zhou B; Wu J; Liu J
Curr Cancer Drug Targets; 2014; 14(2):156-66. PubMed ID: 24274397
[TBL] [Abstract][Full Text] [Related]
8. Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression.
Nakamae I; Morimoto T; Shima H; Shionyu M; Fujiki H; Yoneda-Kato N; Yokoyama T; Kanaya S; Kakiuchi K; Shirai T; Meiyanto E; Kato JY
Molecules; 2019 Nov; 24(22):. PubMed ID: 31717651
[TBL] [Abstract][Full Text] [Related]
9. Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway.
Pan LL; Wu WJ; Zheng GF; Han XY; He JS; Cai Z
Z Naturforsch C J Biosci; 2017 Oct; 72(11-12):441-447. PubMed ID: 28902633
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells.
Mutlu Altundağ E; Yılmaz AM; Koçtürk S; Taga Y; Yalçın AS
Nutr Cancer; 2018 Jan; 70(1):97-108. PubMed ID: 29161179
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
[TBL] [Abstract][Full Text] [Related]
12. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models.
Kamitani N; Nakamae I; Yoneda-Kato N; Kato JY; Sho M
Sci Rep; 2022 Dec; 12(1):22419. PubMed ID: 36575213
[TBL] [Abstract][Full Text] [Related]
14. Curcumin induces apoptosis and cell cycle arrest via the activation of reactive oxygen species-independent mitochondrial apoptotic pathway in Smad4 and p53 mutated colon adenocarcinoma HT29 cells.
Agarwal A; Kasinathan A; Ganesan R; Balasubramanian A; Bhaskaran J; Suresh S; Srinivasan R; Aravind KB; Sivalingam N
Nutr Res; 2018 Mar; 51():67-81. PubMed ID: 29673545
[TBL] [Abstract][Full Text] [Related]
15. Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia.
Guo Y; Li Y; Shan Q; He G; Lin J; Gong Y
Int J Biochem Cell Biol; 2015 Aug; 65():1-11. PubMed ID: 25979368
[TBL] [Abstract][Full Text] [Related]
16. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
17. Aurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I Mutation.
Wang LX; Wang JD; Chen JJ; Long B; Liu LL; Tu XX; Luo Y; Hu Y; Lin DJ; Lu G; Long ZJ; Liu Q
Sci Rep; 2016 Nov; 6():35533. PubMed ID: 27824120
[TBL] [Abstract][Full Text] [Related]
18. Curcumin Analog Pentagamavunon-1 (PGV-1) Sensitizes Widr Cells to 5-Fluorouracil through Inhibition of NF-κB Activation.
Meiyanto E; Septisetyani EP; Larasati YA; Kawaichi M
Asian Pac J Cancer Prev; 2018 Jan; 19(1):49-56. PubMed ID: 29373892
[TBL] [Abstract][Full Text] [Related]
19. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells.
Wolanin K; Magalska A; Mosieniak G; Klinger R; McKenna S; Vejda S; Sikora E; Piwocka K
Mol Cancer Res; 2006 Jul; 4(7):457-69. PubMed ID: 16849521
[TBL] [Abstract][Full Text] [Related]
20. Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics.
Wang L; Chen X; Du Z; Li G; Chen M; Chen X; Liang G; Chen T
J Exp Clin Cancer Res; 2017 Mar; 36(1):47. PubMed ID: 28359291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
